APA način citiranja

van der Meulen, M., Zamanipoor Najafabadi, A. H., Lobatto, D. J., Andela, C. D., Vliet Vlieland, T. P. M., Pereira, A. M., . . . Biermasz, N. R. (2020). SF-12 or SF-36 in pituitary disease? Toward concise and comprehensive patient-reported outcomes measurements. Endocrine.

Čikaški stil citiranja

van der Meulen, Merel, Amir H. Zamanipoor Najafabadi, Daniel J. Lobatto, Cornelie D. Andela, Thea P. M. Vliet Vlieland, Alberto M. Pereira, Wouter R. van Furth, i Nienke R. Biermasz. "SF-12 or SF-36 in Pituitary Disease? Toward Concise and Comprehensive Patient-reported Outcomes Measurements." Endocrine 2020.

MLA način citiranja

van der Meulen, Merel, et al. "SF-12 or SF-36 in Pituitary Disease? Toward Concise and Comprehensive Patient-reported Outcomes Measurements." Endocrine 2020.